Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8458694 | Radiotherapy and Oncology | 2018 | 12 Pages |
Abstract
Finally, important research avenues for improvement of proton radiotherapy based on radiobiological knowledge are identified. The clinical distribution of radiobiological effectiveness of protons alone or in combination with systemic chemo- or immunotherapies as well as patient stratification based on biomarker expressions are key to reach the full potential of proton beam therapy. Dedicated preclinical experiments, innovative clinical trial designs, and large high-quality data repositories will be most important to achieve this goal.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Armin Lühr, Cläre von Neubeck, Jörg Pawelke, Annekatrin Seidlitz, Claudia Peitzsch, Søren M. Bentzen, Thomas Bortfeld, Jürgen Debus, Eric Deutsch, Johannes A. Langendijk, Jay S. Loeffler, Radhe Mohan, Michael Scholz, Brita S. Sørensen,